This is a synthetic peptide designed for use in combination with anti-NAPSA Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
限制
仅限研究用
状态
Lyophilized
溶解方式
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
浓度
1 mg/mL
缓冲液
Final peptide concentration is 1 mg/mL in PBS.
注意事项
Avoid repeated freeze-thaw cycles.
储存条件
-20 °C
储存方法
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
抗原
NAPSA
(Napsin A Aspartic Peptidase (NAPSA))
别名
KAP Peptide, Kdap Peptide, NAP1 Peptide, NAPA Peptide, SNAPA Peptide, pronapsin Peptide, kap Peptide, kdap Peptide, nap1 Peptide, napa Peptide, napsa Peptide, snapa Peptide, napsin A aspartic peptidase Peptide, napsin A aspartic peptidase L homeolog Peptide, NAPSA Peptide, Napsa Peptide, napsa.L Peptide
背景
The activation peptides of aspartic proteinases plays role as inhibitors of the active site. These peptide segments, or pro-parts, are deemed important for correct folding, targeting, and control of the activation of aspartic proteinase zymogens. The pronapsin A gene is expressed predominantly in lung and kidney. Its translation product is predicted to be a fully functional, glycosylated aspartic proteinase precursor containing an RGD motif and an additional 18 residues at its C-terminus.